NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Cannabis Stocks
The 3 Worst-Performing Marijuana Stocks of 2019

Cannabis Stocks
Whatever Happened to Tilray (NASDAQ:TLRY)?

Cannabis Stocks
2 Pot Stocks That Are up Over 50% Year to Date (And 1 That’s Struggling!)

Dividend Stocks
Marijuana’s Next Ally? Look No Further Than the Big Six

Cannabis Stocks
Better Buy: Tilray (NASDAQ:TLRY) or Canopy Growth Corp (TSX:WEED)?

Cannabis Stocks
3 Pot Stocks That Are Much Better Than Aurora Cannabis Inc (TSX:ACB)

Cannabis Stocks
Marijuana Stocks: Why Tilray Inc. (NASDAQ:TLRY) Remains a Top Buy

Cannabis Stocks
This Tiny Marijuana Stock Is a Better Bet Than Tilray (NASDAQ:TLRY) or Canopy Growth (TSX:WEED)

Stocks for Beginners
Pot Stock Round-Up: 4 of the Best Cannabis-Related Companies

Cannabis Stocks
Could Tilray (NASDAQ:TLRY) Outpace Aurora Cannabis (TSX:ACB) and Canopy Growth (TSX:WEED) in Europe?

Dividend Stocks
Are These the Best Canadian Growth Stocks Money Can Buy?
